Literature DB >> 2715302

Tubal infertility and silent chlamydial salpingitis.

S Osser1, K Persson, P Liedholm.   

Abstract

Antibodies to Chlamydia trachomatis (serum IgG antibodies with a titre of at least 32) were detected in 141 (86.0%) of 164 infertile women with tubal infertility (TF group) and in 20 (28.6%) in 70 infertile women with normal tubes (NTF group). The difference was highly significant (P less than 0.001), as was the difference in geometric mean titre of antibody-positive cases, 181 and 87, respectively. Pregnant, age-matched women were used as controls. Significantly fewer of these women (P less than 0.001) had antibodies, when compared with the TF group, 60 (36.6%) of 164, but not when the comparison was made with the NTF group, 31 (44.3%) of 70. There was a history of salpingitis in 64 (39.0%) of the 164 infertile women with damaged tubes. Neither the frequency nor the geometric mean titre of chlamydial antibodies differed between tubal factor infertility patients with and without a history of salpingitis. Previous chlamydial infection, reflected by serological markers, is strongly associated with tubal damage leading to tubal infertility. A large proportion of these cases run a silent course, since a majority of the antibody-positive patients with tubal infertility have never had salpingitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715302     DOI: 10.1093/oxfordjournals.humrep.a136888

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Prevalence of asymptomatic carriers of Chlamydia trachomatis among pregnant and non-pregnant women in south-western Greece.

Authors:  T Arkoulis; G Decavalas; M Papapetropoulou; J Detorakis; X Kondakis; V Tzigounis
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

2.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

3.  Chlamydial genital infections and laparoscopic findings in infertile women.

Authors:  A Lucisano; G Morandotti; R Marana; F Leone; G Branca; S Dell'Acqua; A Sanna
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

4.  Association of Chlamydia trachomatis with tubal infertility.

Authors:  R N Roberts; A J Quinn; W Thompson; R D Maw; D E Wyatt; R B Beattie
Journal:  Ir J Med Sci       Date:  1993-01       Impact factor: 1.568

5.  New sexual partners and readiness to seek screening for chlamydia and gonorrhoea: predictors among minority young women.

Authors:  M R Chacko; C M Wiemann; C A Kozinetz; R J Diclemente; P B Smith; M M Velasquez; K von Sternberg
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

6.  Young women's perspective of the pros and cons to seeking screening for chlamydia and gonorrhea: an exploratory study.

Authors:  Mariam R Chacko; Kirk von Sternberg; Mary M Velasquez; Constance M Wiemann; Peggy B Smith; Ralph DiClemente
Journal:  J Pediatr Adolesc Gynecol       Date:  2008-08       Impact factor: 1.814

7.  Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis.

Authors:  Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker
Journal:  Sex Transm Infect       Date:  2019-12-13       Impact factor: 3.519

8.  Current Chlamydia trachomatis Infection, A Major Cause of Infertility.

Authors:  Jayanti Mania-Pramanik; Shilpa Kerkar; Shobha Sonawane; Pratibha Mehta; Vinita Salvi
Journal:  J Reprod Infertil       Date:  2012-10

9.  Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model.

Authors:  Malcolm J Price; A E Ades; Daniela De Angelis; Nicky J Welton; John Macleod; Kate Soldan; Ian Simms; Katy Turner; Paddy J Horner
Journal:  Am J Epidemiol       Date:  2013-06-27       Impact factor: 4.897

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.